Acute Effects of Cannabigerol

• Status: Not yet recruiting
• Trial end date: 2024-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine the effects of hemp-derived cannabigerol (CBG) on anxiety, stress, mood, and cognition. Further, the severity of various side effects of CBG (sleepiness, dry mouth, dry eyes, increased appetite) will be assessed. As such, the study is focused on better understanding some of the potentially beneficial and detrimental effects of CBG on humans.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Washington State University

Criteria

Inclusion Criteria

• 21+ years of age

• reside in Washington state

• own a smartphone

• have access to a private environment where they can access a computer with a webcam connected to a high-quality and stable internet

• speak fluent English

• be literate

• have experience using CBG without serious adverse reactions

Exclusion Criteria

• serious psychiatric disorders (e.g., psychotic disorder, bipolar disorder)

• neurological and other serious medical conditions including head injury

• pregnancy, or breastfeeding

• use of illicit substances in past 3 months

• heavy use of alcohol.